AstraZeneca (Zoladex commercial rights) Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
AstraZeneca (Zoladex commercial rights) General Information
Description
The commercial distribution rights of Zoladex in the United States of America and Canada. The rights are that of an injectable luteinising hormone-releasing hormone agonist, used to treat prostate cancer, breast cancer and certain benign gynaecological disorders.
Contact Information
Corporate Office
- 2 Kingdom Street
- London W2 6BD
- England, United Kingdom
Corporate Office
- 2 Kingdom Street
- London W2 6BD
- England, United Kingdom
AstraZeneca (Zoladex commercial rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AstraZeneca (Zoladex commercial rights) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
AstraZeneca (Zoladex commercial rights) FAQs
-
When was AstraZeneca (Zoladex commercial rights) founded?
AstraZeneca (Zoladex commercial rights) was founded in 2006.
-
Where is AstraZeneca (Zoladex commercial rights) headquartered?
AstraZeneca (Zoladex commercial rights) is headquartered in London, United Kingdom.
-
What industry is AstraZeneca (Zoladex commercial rights) in?
AstraZeneca (Zoladex commercial rights)’s primary industry is Distributors (Healthcare).
-
Is AstraZeneca (Zoladex commercial rights) a private or public company?
AstraZeneca (Zoladex commercial rights) is a Private company.
-
What is the current valuation of AstraZeneca (Zoladex commercial rights)?
The current valuation of AstraZeneca (Zoladex commercial rights) is .
-
What is AstraZeneca (Zoladex commercial rights)’s current revenue?
The current revenue for AstraZeneca (Zoladex commercial rights) is .
-
Who are AstraZeneca (Zoladex commercial rights)’s investors?
AstraZeneca has invested in AstraZeneca (Zoladex commercial rights).
-
When was AstraZeneca (Zoladex commercial rights) acquired?
AstraZeneca (Zoladex commercial rights) was acquired on 31-Mar-2017.
-
Who acquired AstraZeneca (Zoladex commercial rights)?
AstraZeneca (Zoladex commercial rights) was acquired by Tersera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process